|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Plasma Industry | |||||
| Pharmaceutical industry | |||||
| Pharma Industry | |||||
| Other Revenue | |||||
| Total revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Selling, general and administrative | |||||
| Depreciation and amortization | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Other income | |||||
| Interest income, net | |||||
| Income before income tax provision | |||||
| Income tax provision | |||||
| Net income | |||||
| Income per share | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average common shares | |||||
| Basic | |||||
| Diluted | |||||
Loading...